Heron Therapeutics Inc (HRTX): Next-Year EPS Estimate 81.25%
As of 2026-06-11, Heron Therapeutics Inc (HRTX) has a next-year EPS growth estimate of 81.25%.
On 2026-06-03, analyst consensus for HRTX's next-year EPS growth shifted from 325.00% to 81.25% — a negative change of 243.75 percentage points. The revised estimate has been sustained across 7 subsequent trading sessions. Current-year growth is projected at 55.56%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 81.25%
- EPS growth this year
- 55.56%
- EPS next quarter (est)
- -$0.01
- Last price
- $0.41
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 81.25% | 55.56% | -$0.01 | $0.41 |
| 2026-06-10 | 81.25% | 55.56% | -$0.01 | $0.41 |
| 2026-06-09 | 81.25% | 55.56% | -$0.01 | $0.40 |
| 2026-06-08 | 81.25% | 55.56% | -$0.01 | $0.45 |
| 2026-06-07 | 81.25% | 55.56% | -$0.01 | $0.43 |
| 2026-06-04 | 81.25% | 55.56% | -$0.01 | $0.48 |
| 2026-06-03 | 81.25% | 55.56% | -$0.01 | $0.45 |
| 2026-06-02 | 325.00% | 72.22% | -$0.01 | $0.45 |
| 2026-06-01 | 325.00% | 72.22% | -$0.01 | $0.83 |
| 2026-05-31 | 325.00% | 72.22% | -$0.01 | $0.87 |
| 2026-05-28 | 325.00% | 72.22% | -$0.01 | $0.89 |
| 2026-05-27 | 325.00% | 72.22% | -$0.01 | $0.91 |
| 2026-05-26 | 325.00% | 72.22% | -$0.01 | $0.88 |
| 2026-05-25 | 325.00% | 72.22% | -$0.01 | $0.86 |
| 2026-05-24 | 325.00% | 72.22% | -$0.01 | $0.86 |
| 2026-05-21 | 325.00% | 72.22% | -$0.01 | $0.87 |
| 2026-05-20 | 325.00% | 72.22% | -$0.01 | $0.85 |
| 2026-05-19 | 325.00% | 72.22% | -$0.01 | $0.85 |
| 2026-05-18 | 325.00% | 72.22% | -$0.01 | $0.86 |
| 2026-05-17 | 325.00% | 72.22% | -$0.01 | $0.85 |
| 2026-05-14 | 325.00% | 72.22% | -$0.01 | $0.91 |
| 2026-05-13 | 325.00% | 72.22% | -$0.01 | $0.94 |
| 2026-05-12 | 325.00% | 72.22% | -$0.01 | $0.96 |
| 2026-05-11 | 300.00% | 75.00% | -$0.01 | $0.96 |
| 2026-05-10 | 549.99% | 77.78% | -$0.02 | $1.21 |
| 2026-05-07 | 549.99% | 77.78% | -$0.02 | $1.24 |
| 2026-05-06 | 549.99% | 77.78% | -$0.02 | $1.31 |
| 2026-05-05 | 549.99% | 77.78% | -$0.02 | $1.23 |
| 2026-05-04 | 549.99% | 77.78% | -$0.02 | $1.22 |
| 2026-05-03 | 549.99% | 77.78% | -$0.02 | $1.27 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Heron Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Heron Therapeutics Inc (HRTX) has a next-year EPS growth estimate of 81.25%, based on analyst consensus.
When was the latest EPS estimate revision for HRTX?▾
The most recent revision occurred on 2026-06-03, when analysts adjusted the next-year EPS growth estimate from 325.00% to 81.25%.
What sector and industry does Heron Therapeutics Inc belong to?▾
Heron Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. HRTX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Heron Therapeutics Inc (HRTX) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports